Finished product reference
Dapoxetine
Tablet · Oral · 30 mg
- List code
- 50640
- Salt form
- Hydrochloride
- Pharmacologic class
- Short-acting selective serotonin reuptake inhibitor (SSRI) for premature ejaculation
What it is and how it works
Dapoxetine inhibits neuronal serotonin reuptake, potentiating serotonergic activity at pre- and post-synaptic receptors involved in the central control of the ejaculatory reflex. Its rapid absorption and elimination make it suitable for on-demand use.
Indications
Treatment of premature ejaculation in men aged 18–64 years who meet defined diagnostic criteria.
Dosage and administration (summary)
30 mg orally taken as needed approximately 1–3 hours before sexual activity, with a full glass of water; may be increased to 60 mg if tolerated. Maximum one dose every 24 hours.
Contraindications
Significant cardiac conditions (heart failure, conduction abnormalities, significant ischaemic or valvular heart disease), history of mania or severe depression, moderate to severe hepatic impairment; concomitant MAOIs, thioridazine, SSRIs, SNRIs, tricyclic antidepressants or other serotonergic drugs, and potent CYP3A4 inhibitors.
Warnings and precautions
Orthostatic hypotension and syncope can occur, particularly at the start of treatment; patients should sit or lie down if prodromal symptoms occur and avoid driving if affected. Avoid alcohol and recreational drugs. Use with caution in epilepsy, bleeding disorders and in patients with risk of raised intra-ocular pressure.
Storage and supply
Store below 30 °C.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.